Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy
- PMID: 15374829
- DOI: 10.1152/ajpheart.00723.2004
Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy
Abstract
The goal of this study was to determine the role of estrogen receptor subtypes in the development of pressure overload hypertrophy in mice. Epidemiological studies have suggested gender differences in the development of hypertrophy and heart disease, but the mechanism and the role of estrogen receptor subtypes are not established. We performed transverse aortic constriction (TAC) and sham operations in male and female wild-type (WT) mice and mice lacking functional estrogen receptor-alpha [alpha-estrogen receptor knockout (alpha-ERKO)] and mice lacking estrogen receptor-beta (beta-ERKO). Body, heart, and lung weights were measured 2 wk postsurgery. WT male mice subjected to TAC showed a 64% increase in the heart weight-to-body weight ratio (HW/BW) compared with sham, and WT males have increased lung weight at 2 wk. WT female mice subjected to TAC showed a 31% increase in HW/BW compared with sham, which was significantly less than their male counterparts and with no evidence of heart failure. alpha-ERKO females developed HW/BW nearly identical to that seen in WT littermate females in response to TAC, indicating that estrogen receptor-alpha is not essential for the attenuation of hypertrophy observed in WT females. In contrast, beta-ERKO females responded to TAC with a significantly greater increase in HW/BW than WT littermate females. beta-ERKO females have lower expression of lipoprotein lipase at baseline than WT or alpha-ERKO females. These data suggest an important role for estrogen receptor-beta in attenuating the hypertrophic response to pressure overload in females.
Similar articles
-
Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload.Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1597-606. doi: 10.1152/ajpregu.00825.2009. Epub 2010 Apr 7. Am J Physiol Regul Integr Comp Physiol. 2010. PMID: 20375266
-
Functional characterization and sex differences in small mesenteric arteries of the estrogen receptor-beta knockout mouse.Am J Physiol Regul Integr Comp Physiol. 2008 Jan;294(1):R112-20. doi: 10.1152/ajpregu.00421.2007. Epub 2007 Oct 24. Am J Physiol Regul Integr Comp Physiol. 2008. PMID: 17959706
-
Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury.J Mol Cell Cardiol. 2005 Feb;38(2):289-97. doi: 10.1016/j.yjmcc.2004.11.013. Epub 2005 Jan 20. J Mol Cell Cardiol. 2005. PMID: 15698835
-
Comparative proteomic analysis reveals sex and estrogen receptor β effects in the pressure overloaded heart.J Proteome Res. 2014 Dec 5;13(12):5829-36. doi: 10.1021/pr500749j. Epub 2014 Nov 19. J Proteome Res. 2014. PMID: 25406860
-
The effects of oestrogen receptors alpha and beta on testicular cell number and steroidogenesis in mice.Reproduction. 2007 Aug;134(2):271-9. doi: 10.1530/REP-07-0025. Reproduction. 2007. PMID: 17660237
Cited by
-
The Role of Estrogen Receptors in Cardiovascular Disease.Int J Mol Sci. 2020 Jun 17;21(12):4314. doi: 10.3390/ijms21124314. Int J Mol Sci. 2020. PMID: 32560398 Free PMC article. Review.
-
Sex-Specific Features of Calcific Aortic Valve Disease.Int J Mol Sci. 2020 Aug 6;21(16):5620. doi: 10.3390/ijms21165620. Int J Mol Sci. 2020. PMID: 32781508 Free PMC article. Review.
-
A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis.Open Heart. 2021 Apr;8(1):e001663. doi: 10.1136/openhrt-2021-001663. Open Heart. 2021. PMID: 33879509 Free PMC article. No abstract available.
-
Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.Am J Respir Crit Care Med. 2012 Jul 15;186(2):125-31. doi: 10.1164/rccm.201201-0058PP. Epub 2012 May 3. Am J Respir Crit Care Med. 2012. PMID: 22561960 Free PMC article. Review.
-
The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling.J Biol Chem. 2019 Feb 15;294(7):2500-2518. doi: 10.1074/jbc.RA118.004926. Epub 2018 Dec 11. J Biol Chem. 2019. PMID: 30538132 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases